1Frantz S, Kobzik L, Kim YD, et al. Toll4 (TLR4) expression in eardiae myoeytes in normal and failing myoeardium, J Clin Invest, 1999, 104 : 271-280.
2Frantz S,Hu K, Bayer B, et al. Absence of NF-kappaB subunit pSO improves heart failure after myocardial infarction. FASEB J, 2006, 20: 1918-1920.
3Satoh M, Shimoda Y, Maesawa C, et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction, Int J Cardiol, 2006, 109: 226-234.
4Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail, 2001, 3: 517-526.
5Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation, 1998, 97: 1375-1381.
6Eriksson U, Ricci R, Hunziker L, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med, 2003, 9: 1484-1490.
7Dunzendorfer S,Lee HK, Soldau K, et al. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. Faseb J, 2004, 18: 1117-1119.
8Li C, Ha T, Kelley J, et al. Modulating Toll-like receptor mediated signaling by ( 1--> 3 )q3-D-glucan rapidly induces cardioprotection. Cardiovas Res, 2004, 61: 538-547.
9Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 1999, 83 : 376-382.
10Becker AE, de Boer O J, van Der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med, 2001, 52 : 289-297.
